• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    o9 Announces Teleflex™ Global Go-Live for Integrated Demand and Supply Planning

    3/12/26 8:02:00 AM ET
    $TFX
    Medical/Dental Instruments
    Health Care
    Get the next $TFX alert in real time by email

    o9, a leading enterprise AI software platform provider for transforming planning and decision-making, today announced that Teleflex Incorporated (NYSE:TFX), a leading global provider of medical technologies, is now live globally with Demand Planning and Supply Planning on the o9 platform. This deployment supports Teleflex's multi-year effort to enhance its end-to-end integrated business planning and supply chain management capabilities.

    With Demand Planning and Supply Planning on one platform, Teleflex now connects demand forecasts and demand planning in a single environment. This integrated approach improves coordination across commercial, operational, and supply teams, enhances visibility into inventory and capacity positions, and enables faster alignment on trade-offs that directly impact service and execution. The rollout supports collaborative workflows and advanced forecasting methods. Teleflex is seeing measurable improvements in forecast performance and cross-functional alignment, establishing a scalable foundation for continued advancement of its integrated business planning capabilities.

    "Going live globally with Demand and Supply Planning strengthens how we align decisions across functions and regions," said David Connaughton, Vice President Global Demand Fulfilment, at Teleflex. "We are seeing improved forecast performance and better coordination across our operations. That helps us manage inventory, reduce back orders, and serve healthcare professionals and patients more reliably in line with our vision to be the most trusted partner in the world of healthcare."

    "Teleflex's go-live reflects meaningful progress toward a more connected enterprise planning model," said Chakri Gottemukkala, Co-founder and CEO of o9. "By bringing demand and supply decisions together within a single platform, Teleflex has strengthened alignment across its global operations and improved how trade-offs are evaluated and executed. That structural coordination is essential to sustaining performance and adapting with confidence in complex environments."

    To learn more, please visit o9solutions.com.

    About o9 Solutions

    o9 Solutions is a leading Enterprise Knowledge and AI-powered platform helping companies build Agile, Adaptive & Autonomous Planning & Execution Models for transforming enterprise decision-making in environments of rising volatility and uncertainty. Whether it is improving forecast accuracy, matching demand and supply and driving collaboration across the multi-tier supply chain to improve resilience at optimal costs and inventory, or optimizing new product and commercial initiatives to drive revenue growth and margins, decision-making processes from long-range to tactical to execution horizon can be made faster and smarter and connected on o9's Digital Brain Platform.

    o9 brings together game-changing technology innovations — such as innovative enterprise knowledge graph modeling, big data analytics, advanced algorithms for forecasting, demand/supply balancing, scenario planning, real time learning, collaboration, generative and agentic AI, easy-to-use interfaces and cloud-based delivery, and innovative management methods — as well as organization, process and change management best practices to transform decision-making speed and intelligence. For more information, please visit www.o9solutions.com.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20260312520262/en/

    Evelien van der Wel

    [email protected]

    Get the next $TFX alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $TFX

    DatePrice TargetRatingAnalyst
    1/27/2026$138.00Hold → Buy
    Needham
    3/4/2025$235.00 → $140.00Neutral → Underperform
    BofA Securities
    2/28/2025$220.00 → $155.00Outperform → Sector Perform
    RBC Capital Mkts
    2/28/2025Outperform → Mkt Perform
    Raymond James
    2/28/2025$255.00 → $140.00Overweight → Neutral
    Piper Sandler
    2/27/2025Mkt Outperform → Mkt Perform
    Citizens JMP
    7/1/2024$205.00 → $245.00Neutral → Overweight
    Piper Sandler
    12/4/2023$261.00Equal-Weight → Overweight
    Morgan Stanley
    More analyst ratings

    $TFX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    o9 Announces Teleflex™ Global Go-Live for Integrated Demand and Supply Planning

    o9, a leading enterprise AI software platform provider for transforming planning and decision-making, today announced that Teleflex Incorporated (NYSE:TFX), a leading global provider of medical technologies, is now live globally with Demand Planning and Supply Planning on the o9 platform. This deployment supports Teleflex's multi-year effort to enhance its end-to-end integrated business planning and supply chain management capabilities. With Demand Planning and Supply Planning on one platform, Teleflex now connects demand forecasts and demand planning in a single environment. This integrated approach improves coordination across commercial, operational, and supply teams, enhances visibili

    3/12/26 8:02:00 AM ET
    $TFX
    Medical/Dental Instruments
    Health Care

    Teleflex Announces Quarterly Dividend

    Teleflex Incorporated (NYSE:TFX) announced today that its Board of Directors declared a quarterly cash dividend of thirty-four cents ($0.34) per share of common stock. The dividend is payable March 31, 2026, to shareholders of record at the close of business on March 6, 2026. Additional information about Teleflex can be obtained from the company's website at teleflex.com. About Teleflex Incorporated As a global provider of medical technologies, Teleflex is driven by our purpose to improve the health and quality of people's lives. Through our vision to become the most trusted partner in healthcare, we offer a diverse portfolio with solutions in the therapy areas of anesthesia, emergency me

    2/26/26 6:45:00 AM ET
    $TFX
    Medical/Dental Instruments
    Health Care

    Teleflex Reports 2025 Financial Results and Full Year 2026 Outlook

    Announces Restructuring to Right-Size and Reduce Cost Structure Related to Announced Strategic Divestitures Teleflex Incorporated (NYSE:TFX) (the "Company") today announced financial results for the year ended December 31, 2025. Full year 2025 continuing operations financial summary1 GAAP revenue from continuing operations of $1,992.7 million, up 17.2% compared to the prior year period1 Adjusted revenue from continuing operations of $1,983.7 million, up 16.3% compared to the prior year period, and up 15.4% on an adjusted constant currency basis2 GAAP diluted EPS from continuing operations of $1.31, compared to $1.21 in the prior year period Adjusted diluted EPS from contin

    2/26/26 6:30:00 AM ET
    $TFX
    Medical/Dental Instruments
    Health Care

    $TFX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Executive Vice President & CFO Deren John was granted 13,784 shares and covered exercise/tax liability with 229 shares, increasing direct ownership by 300% to 18,073 units (SEC Form 4)

    4 - TELEFLEX INC (0000096943) (Issuer)

    3/5/26 5:59:07 PM ET
    $TFX
    Medical/Dental Instruments
    Health Care

    CVP, General Counsel & Secty Logue Daniel V. was granted 9,853 shares and covered exercise/tax liability with 131 shares, increasing direct ownership by 65% to 24,653 units (SEC Form 4)

    4 - TELEFLEX INC (0000096943) (Issuer)

    3/5/26 5:59:14 PM ET
    $TFX
    Medical/Dental Instruments
    Health Care

    Corp. VP & Chief HR Officer Hicks Cameron P was granted 8,096 shares and covered exercise/tax liability with 98 shares, increasing direct ownership by 70% to 19,363 units (SEC Form 4)

    4 - TELEFLEX INC (0000096943) (Issuer)

    3/5/26 5:59:01 PM ET
    $TFX
    Medical/Dental Instruments
    Health Care

    $TFX
    SEC Filings

    View All

    SEC Form 10-K filed by Teleflex Incorporated

    10-K - TELEFLEX INC (0000096943) (Filer)

    2/27/26 4:11:36 PM ET
    $TFX
    Medical/Dental Instruments
    Health Care

    Teleflex Incorporated filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Costs Associated with Exit or Disposal Activities, Financial Statements and Exhibits

    8-K - TELEFLEX INC (0000096943) (Filer)

    2/26/26 7:00:43 AM ET
    $TFX
    Medical/Dental Instruments
    Health Care

    Teleflex Incorporated filed SEC Form 8-K: Leadership Update

    8-K - TELEFLEX INC (0000096943) (Filer)

    1/23/26 5:00:20 PM ET
    $TFX
    Medical/Dental Instruments
    Health Care

    $TFX
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Randle Stuart A bought $115,860 worth of shares (1,000 units at $115.86), increasing direct ownership by 15% to 7,547 units (SEC Form 4)

    4 - TELEFLEX INC (0000096943) (Issuer)

    8/7/25 6:02:01 PM ET
    $TFX
    Medical/Dental Instruments
    Health Care

    Director Krakauer Andrew A bought $115,250 worth of shares (1,000 units at $115.25), increasing direct ownership by 16% to 7,192 units (SEC Form 4)

    4 - TELEFLEX INC (0000096943) (Issuer)

    8/7/25 4:15:44 PM ET
    $TFX
    Medical/Dental Instruments
    Health Care

    Chairman, President & CEO Kelly Liam bought $172,605 worth of shares (1,500 units at $115.07), increasing direct ownership by 3% to 45,267 units (SEC Form 4)

    4 - TELEFLEX INC (0000096943) (Issuer)

    8/7/25 4:14:44 PM ET
    $TFX
    Medical/Dental Instruments
    Health Care

    $TFX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Teleflex upgraded by Needham with a new price target

    Needham upgraded Teleflex from Hold to Buy and set a new price target of $138.00

    1/27/26 8:35:45 AM ET
    $TFX
    Medical/Dental Instruments
    Health Care

    Teleflex downgraded by BofA Securities with a new price target

    BofA Securities downgraded Teleflex from Neutral to Underperform and set a new price target of $140.00 from $235.00 previously

    3/4/25 7:44:32 AM ET
    $TFX
    Medical/Dental Instruments
    Health Care

    Teleflex downgraded by RBC Capital Mkts with a new price target

    RBC Capital Mkts downgraded Teleflex from Outperform to Sector Perform and set a new price target of $155.00 from $220.00 previously

    2/28/25 7:34:55 AM ET
    $TFX
    Medical/Dental Instruments
    Health Care

    $TFX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Teleflex Incorporated

    SC 13G/A - TELEFLEX INC (0000096943) (Subject)

    11/14/24 1:28:29 PM ET
    $TFX
    Medical/Dental Instruments
    Health Care

    Amendment: SEC Form SC 13G/A filed by Teleflex Incorporated

    SC 13G/A - TELEFLEX INC (0000096943) (Subject)

    11/8/24 10:29:30 AM ET
    $TFX
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G/A filed by Teleflex Incorporated (Amendment)

    SC 13G/A - TELEFLEX INC (0000096943) (Subject)

    2/14/24 10:04:36 AM ET
    $TFX
    Medical/Dental Instruments
    Health Care

    $TFX
    Leadership Updates

    Live Leadership Updates

    View All

    Diality Appoints Peter Donato as Chief Financial Officer

    Life sciences veteran brings private and public sector expertise to company in midst of growth trajectory Diality Inc., a medical device company that has developed the Moda-flx™ Hemodialysis System, today announced it has named Peter Donato as its chief financial officer. Donato joins the company as it continues to enroll patients in the PRESCRIBE Diality Home Hemodialysis Clinical Trial of its Moda-flx Hemodialysis System while preparing for a limited market release in 2027. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260224064413/en/Diality CFO Peter Donato. Donato joins Diality with nearly 35 years of financial leadershi

    2/24/26 7:05:00 AM ET
    $MYGN
    $STIM
    $TFX
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care
    Medical/Dental Instruments
    Pharmaceuticals and Biotechnology

    Teleflex Announces Leadership Transition

    Stuart Randle Appointed Interim President and CEO Board Initiates Search for Permanent CEO Dr. Stephen Klasko Appointed Chairman of the Board Company Provides Update on Preliminary Full Year 2025 Revenue Results WAYNE, Pa., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE:TFX) today announced that Stuart Randle, a member of the Company's Board of Directors, has been appointed Interim President and Chief Executive Officer, effective immediately. Mr. Randle succeeds Liam Kelly, who departs as Chairman, President and CEO of the Company. Dr. Stephen Klasko, the Company's Lead Director, has been named Chairman of the Board. The Board has engaged Spencer Stuart, a leading execu

    1/8/26 6:30:00 AM ET
    $TFX
    Medical/Dental Instruments
    Health Care

    DoorDash, TKO Group Holdings, Williams-Sonoma and Expand Energy Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400 and S&P SmallCap 600

    NEW YORK, March 7, 2025 /PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI") will make the following changes to the S&P 100, S&P 500, S&P MidCap 400, and S&P SmallCap 600 indices effective prior to the open of trading on Monday, March 24, to coincide with the quarterly rebalance. The changes ensure each index is more representative of its market capitalization range. All companies being added to the S&P 100 are more representative of the mega-cap market space. All companies being added to the S&P 500 are more representative of the large-cap market space, all companies being added to the S&P MidCap 400 are more representative of the mid-cap market space, and all companies being added to the S&P

    3/7/25 6:19:00 PM ET
    $ALK
    $AMBC
    $ATI
    Air Freight/Delivery Services
    Consumer Discretionary
    Property-Casualty Insurers
    Finance

    $TFX
    Financials

    Live finance-specific insights

    View All

    Teleflex Announces Quarterly Dividend

    Teleflex Incorporated (NYSE:TFX) announced today that its Board of Directors declared a quarterly cash dividend of thirty-four cents ($0.34) per share of common stock. The dividend is payable March 31, 2026, to shareholders of record at the close of business on March 6, 2026. Additional information about Teleflex can be obtained from the company's website at teleflex.com. About Teleflex Incorporated As a global provider of medical technologies, Teleflex is driven by our purpose to improve the health and quality of people's lives. Through our vision to become the most trusted partner in healthcare, we offer a diverse portfolio with solutions in the therapy areas of anesthesia, emergency me

    2/26/26 6:45:00 AM ET
    $TFX
    Medical/Dental Instruments
    Health Care

    Teleflex Reports 2025 Financial Results and Full Year 2026 Outlook

    Announces Restructuring to Right-Size and Reduce Cost Structure Related to Announced Strategic Divestitures Teleflex Incorporated (NYSE:TFX) (the "Company") today announced financial results for the year ended December 31, 2025. Full year 2025 continuing operations financial summary1 GAAP revenue from continuing operations of $1,992.7 million, up 17.2% compared to the prior year period1 Adjusted revenue from continuing operations of $1,983.7 million, up 16.3% compared to the prior year period, and up 15.4% on an adjusted constant currency basis2 GAAP diluted EPS from continuing operations of $1.31, compared to $1.21 in the prior year period Adjusted diluted EPS from contin

    2/26/26 6:30:00 AM ET
    $TFX
    Medical/Dental Instruments
    Health Care

    Teleflex Announces Fourth Quarter 2025 Earnings Conference Call Information

    Teleflex Incorporated (NYSE:TFX) will host a conference call to discuss its fourth quarter 2025 financial results and provide an operational update at 8:00 a.m. Eastern Time on Thursday, February 26, 2026. To participate in the conference call, please utilize this link to pre-register and receive the dial-in information. The call can also be accessed through a live audio webcast on the company's website, teleflex.com. An audio replay of the call will be available beginning at 11:00 am Eastern Time on February 26, 2026, either on the Teleflex website or by telephone. The call can be accessed by dialing 1 800 770 2030 (U.S. and Canada) or 1 609 800 9909 (all other locations). The conferen

    2/17/26 6:30:00 AM ET
    $TFX
    Medical/Dental Instruments
    Health Care